Approvals/TGA/OPUVIZ aflibercept 40 mg/mL solution for intravitreal injection in vial with needle

Approved

STANDARD

OPUVIZ aflibercept 40 mg/mL solution for intravitreal injection in vial with needle

Samsung Bioepis AU Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: 4d51a208f3435e4d
Product Name: OPUVIZ aflibercept 40 mg/mL solution for intravitreal injection in vial with needle
Artg Id: 456528
Artg Name: OPUVIZ aflibercept 40 mg/mL solution for intravitreal injection in vial with needle
Sponsor: Samsung Bioepis AU Pty Ltd
Company Detail Path: /organization/samsung-bioepis-au-pty-ltd
Artg Date: 2025-09-18
Registration Type: Medicine
Therapeutic Good Type: Medicines
Licence Status: A
Licence Category: RE

Approved

Agency

TGA

Country

🇦🇺

Approval Date

Sep 19, 2025

Approval ID

4d51a208f3435e4d

Type

Standard